Postpartum blood loss with and without use of prophylactic carbetocin during .. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage. Postpartum haemorrhage (PPH) is the leading cause of maternal mortality Carbetocin may be an underused uterotonic for prevention of PPH. Postpartum haemorrhage (PPH) is defined as blood loss of ml or more within carbetocin versus prostaglandins for the prevention of PPH were reviewed.

Author: Gorg Mogore
Country: Switzerland
Language: English (Spanish)
Genre: Career
Published (Last): 27 May 2014
Pages: 256
PDF File Size: 5.11 Mb
ePub File Size: 14.78 Mb
ISBN: 552-4-52903-706-2
Downloads: 89824
Price: Free* [*Free Regsitration Required]
Uploader: Meztigul

After an uncomplicated vaginal birth in a health care facility, healthy mothers and newborns should receive care in the facility for at least 24 hours after birth.

Skip to main content.

Implementation considerations The successful introduction of evidence-based policies related to the prevention and management of PPH into national programmes and health care services depends on well-planned and participatory consensus-driven processes of adaptation and implementation.

This group of independent experts used the evidence profiles to assess evidence on effects on the pre-specified outcomes. Evidence was extrapolated from one systematic review which evaluated a pgeventing of lostpartum and doses of misoprostol versus injectable uterotonics for the prevention of PPH. Medical eligibility criteria for contraceptive use.

Carbetocin for preventing postpartum haemorrhage.

Most of these deaths occur during the first 24 hours after birth. Syntometrine is more effective than oxytocin but is associated with more side effects. This review of ten randomized controlled trials women provided evidence related to the effect of misoprostol on the management of PPH.

In settings where IV oxytocin is unavailable to women who have received prophylactic IM oxytocin during the third stage of labour, the GDG considered misoprostol to be a valid alternative.


Cochrane Database Syst Rev. No difference was observed in the risk of blood loss, the additional use of uterotonics, or the need for blood transfusion. This video highlights the importance of social support provided by lay labour companions doulas during labour.

Active management of third stage of labour Education material for teachers of midwifery.

There was a problem providing the content you requested

Six Cochrane systematic reviews provided evidence. The incidence of postpartum hypertension was also significantly lower in women who received carbetocin compared to those who received syntometrine.

An increased risk of hyperthermia, vomiting and shivering was observed. Related links WHO recommendations on prevention and treatment of postpartum haemorrhage – full prfventing and evidence tables Managing Complications in Pregnancy and Childbirth: There was no statistically significant difference between the two groups with regard to blood loss, the use of blood transfusion, or the use of additional uterotonics.

No differences in blood transfusion in women receiving oxytocin compared with women receiving ergometrine RR 3. WHO recommendations on prevention and treatment of postpartum haemorrhage – full document and evidence tables. Active versus expectant management for women in the third stage of labour. Prophylactic oxytocin for prebenting third stage of labour to prevent postpartum haemorrhage.

For women in the postoperative period after the surgical repair of a simple obstetric urinary fistula, short duration bladder catheterization 7 to 10 days is recommended as an alternative to longer duration of catheterization. WHO recommendations on interventions to improve preterm birth outcomes.

Carbetocin versus carbetcin Evidence came from one systematic review of 11 trials women which evaluated the effect of carbetocin mcg as an IV bolus or IM ppreventing for the prevention of PPH after vaginal delivery and caesarean section versus oxytocin, fixed dose oxytocin-ergometrine, and placebo. Among the important adverse maternal outcomes reported, lower rates of nausea RR 0.


Recommendation question For this recommendation, we aimed to answer the following question: Education material for teachers of midwifery.

One trial compared the use of intravenous carbetocin with placebo. Two review authors independently assessed trials for inclusion, assessed risk of bias and extracted data.

In the three studies that reported on the use of blood transfusion, the effect was uncertain as the confidence interval included both benefit and harm RR 1.

To determine if the use of oxytocin agonist is as effective as conventional uterotonic agents for the prevention of PPH, and assess the best routes of administration and optimal doses of oxytocin agonist.

Carbetocin for preventing postpartum haemorrhage.

Of the 60 patients in the group receiving IM prostaglandin, two required the use of additional uterotonics, compared to 10 of the 60 patients who received rectal misoprostol RR 0. It includes recommendations for iron supplementation in countries where malaria is carbetocni Evidence summary One Cochrane systematic review was conducted to assess the effectiveness and safety of any intervention used for the treatment of primary PPH. Medical eligibility criteria for contraceptive use MECthe first edition of which was published inhaemorrrhage current WHO guidance on the safety of various contraceptive methods for use in the context When compared to oxytocin, carbetocin was associated with a reduced use of additional uterotonic drugs after caesarean delivery RR 0.